Survival Analysis and the Effect of Censoring for Lung Cancer
Principal Investigator
Name
Azar Shahraz
Degrees
Ph.D.
Institution
AstraZeneca
Position Title
Associate Director
Email
About this CDAS Project
Study
PLCO
(Learn more about this study)
Project ID
PLCO-991
Initial CDAS Request Approval
Jul 22, 2022
Title
Survival Analysis and the Effect of Censoring for Lung Cancer
Summary
The aim of this project is to study the effect of censoring in survival analysis in oncology clinical trial.
We want to investigate the best parametric/semi parametric models for survival analysis and study the effect of censoring on each type.
We want to investigate the best parametric/semi parametric models for survival analysis and study the effect of censoring on each type.
Aims
The aim of this project is to study the effect of censoring in survival analysis in oncology clinical trial.
Collaborators
No collaborator.